Chronic Hepatitis C
Showing 1 - 25 of 351
Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or
Active, not recruiting
- Chronic Hepatitis C
- People Who Inject Drugs
- velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
-
Atlanta, GeorgiaWellstar Atlanta Medical Center
May 31, 2023
Protease Inhibitors in Chronic Hepatitis C
Completed
- Chronic Hepatitis C
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
Jan 11, 2023
Long Term Follow-up of Hepatitis C Cured Patients
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Sep 19, 2022
Long Term Follow up of Chronic HCV Patients Receiving DAAS
Recruiting
- Chronic Hepatitis c
-
Sohag, EgyptSohag University Hospital
Jun 29, 2022
Chronic Hepatitis C Trial in Hines (20mg ezetimibe, Placebo, 40mg ezetimibe)
Terminated
- Chronic Hepatitis C
- 20mg ezetimibe
- +2 more
-
Hines, IllinoisEdward Hines Jr. VA Hospital, Hines, IL
May 10, 2022
Determine Hepatitis C Virus Infection Prevalence Among Patients
Completed
- Chronic Hepatitis c
- Vasculitis
-
Mexico City, MexicoHospital General de Mexico
Mar 15, 2022
Hepatocellular Carcinoma in HIV-infected Patients
Completed
- Hepatocellular Carcinoma
- +4 more
-
Orihuela, Alicante, Spain
- +29 more
Mar 15, 2022
End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])
Withdrawn
- End Stage Renal Disease
- Chronic Hepatitis c
- Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
-
Boston, MassachusettsMassachusetts General Hospital
Mar 4, 2022
Chronic Hepatitis c Trial in Assiut (lipid profile, fasting insulin, fibro scan)
Recruiting
- Chronic Hepatitis c
- lipid profile
- +2 more
-
Assiut, EgyptAssiut University hospital
Feb 23, 2022
Chronic Hepatitis C Trial in Chapel Hill (VC-CBCS)
Completed
- Chronic Hepatitis C
- VC-CBCS
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Jan 6, 2022
Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with
Completed
- Chronic Hepatitis C
- SOF/LDV (sofosbuvir/ledipasvir)
- +3 more
-
Little Rock, Arkansas
- +37 more
Dec 1, 2021
Fixed-dose Combination Sofosdac® 400mg/60mg in Chronic Hepatitis
Completed
- Chronic Hepatitis c
- Sofosdac®
-
Boufarik, Blida, Algeria
- +3 more
Nov 16, 2021
Chronic Kidney Disease, Chronic Hepatitis C Trial in Boston (Viekira Pak ± ribavirin, Mavyret)
Completed
- Chronic Kidney Disease
- Chronic Hepatitis C
- Viekira Pak ± ribavirin
- Mavyret
-
Boston, MassachusettsMassachusetts General Hospital
Oct 5, 2021
Enhancing Access to Care for Chronic Hepatitis C Infected
Recruiting
- Chronic Hepatitis c
- Intravenous Drug Usage
-
Hong Kong, Please Select One ..., Hong KongMan Fung Yuen
Sep 28, 2021
Chinese Participants With Chronic Hepatitis C (CHC)
Terminated
- Chronic Hepatitis C
-
Beijing, Beijing, China
- +1 more
Aug 27, 2021
Chronic Hepatitis C Trial in Porto Alegre (Telemedicine, Velpatasvir/Sofosbuvir)
Active, not recruiting
- Chronic Hepatitis C
- Telemedicine
- Velpatasvir/Sofosbuvir
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clínicas de Porto Alegre
Aug 24, 2021
Hepatitis C, Chronic Hepatitis c, Hepatitis C, Chronic Trial in Melbourne (EC clinic support - whole of practice interventions
Recruiting
- Hepatitis C
- +2 more
- EC clinic support - whole of practice interventions delivery through nurse-led model
-
Melbourne, Victoria, AustraliaBurnet Institute
Aug 22, 2021
Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)
Recruiting
- Chronic Hepatitis C
- Chronic Hepatitis B
- Tenofovir Alafenamide 25 MG
- Sofosbuvir / Velpatasvir
-
Beijing, Beijing, ChinaPeking University First Hospital
Aug 2, 2021
Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))
Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)
Chronic Hepatitis C Trial in Parma (blood drawing)
Completed
- Chronic Hepatitis C
- blood drawing
-
Parma, ItalyUnit of Infectious Diseases and Hepatology
Jul 20, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-493 coformulated with ABT-530
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021